Kochi: Cancer diagnosis and related tests are available at very low rates in the pathology department of Govt Medical College ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Daiichi Sankyo and AstraZeneca's Enhertu has been cleared for previously-untreated HER2-positive breast cancer in the US, becoming the first new first-line option in more than a decade. The FDA ...

Abu Dhabi, United Arab Emirates – Fasset, a leading global banking and investment platform, today announced a strategic partnership agreement with ADI Foundation (ADI), an Abu Dhabi-based non-profit ...

Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...

Daiichi Sankyo begins patient dosing in DESTINY-Endometrial02 phase 3 trial of Enhertu in patients with HER2 expressing endometrial cancer: Tokyo Tuesday, December 23, 2025, 10:00 ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

Calling on lawyers to support Imran Khan, Afridi said the PTI founder was facing "oppression and barbarity" and stressed that ...

From scrambled eggs to seasoned ground meat and roasted veggies, these burritos check all the macros — and they’re freezer-ready, reheatable, and totally crave-worthy. Perfect for group workouts or ...

Upholding the State Commission's order, the National Consumer Disputes Redressal Commission (NCDRC) has held a Ludhiana-based ...

NASA’s spaceflight microbiology and environmental chemistry research monitors and analyzes microorganisms, air, and water aboard spacecraft to support crew health systems and maintain operational ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...